Literature DB >> 9582927

Novel pneumococcal surface proteins: role in virulence and vaccine potential.

J C Paton1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9582927     DOI: 10.1016/s0966-842x(98)01220-7

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


× No keyword cloud information.
  30 in total

Review 1.  New pneumococcal vaccines for children.

Authors:  S Choo; A Finn
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

2.  Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.

Authors:  D E Briles; E Ades; J C Paton; J S Sampson; G M Carlone; R C Huebner; A Virolainen; E Swiatlo; S K Hollingshead
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Virulence of Streptococcus pneumoniae: PsaA mutants are hypersensitive to oxidative stress.

Authors:  Hsing-Ju Tseng; Alastair G McEwan; James C Paton; Michael P Jennings
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

4.  The solution structure and oligomerization behavior of two bacterial toxins: pneumolysin and perfringolysin O.

Authors:  Alexandra S Solovyova; Marcelo Nöllmann; Timothy J Mitchell; Olwyn Byron
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

Review 5.  Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.

Authors:  Q Zhang; A Finn
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

6.  Mn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence.

Authors:  Jason W Johnston; David E Briles; Lisa E Myers; Susan K Hollingshead
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

7.  Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.

Authors:  A D Ogunniyi; M C Woodrow; J T Poolman; J C Paton
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

8.  Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.

Authors:  B P Arulanandam; J M Lynch; D E Briles; S Hollingshead; D W Metzger
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

9.  Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children.

Authors:  Qibo Zhang; Sharon Choo; Adam Finn
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins.

Authors:  Josée Hamel; Nathalie Charland; Isabelle Pineau; Catherine Ouellet; Stéphane Rioux; Denis Martin; Bernard R Brodeur
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.